May 26, 2026

Weight Loss, Adverse Effects With GLP-1 Medications May Be Influenced by Genetics

Key Points

Key points are not available for this paper at this time.

Abstract

This Medical News article discusses findings that genetic variants may affect patients’ responses to glucagon-like peptide-1 receptor agonists such as semaglutide and tirzepatide.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

Samantha Anderer

Journals

JAMA

Actions

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Weight Loss, Adverse Effects With GLP-1 Medications May Be Influenced by Genetics

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study